HOME › Research Insight › Innovative And Advanced of Bioinformatics Technologies
Innovative And Advanced of Bioinformatics Technologies
Bioinformatics is an integration of informatics and life sciences. It uses information technology, statistics, and algorithms for storing, retrieving, and analyzing biological data that is generated during life sciences research.In Latin America, bioinformatics is now widely recognized as a crucial field for research and development in agricultural, veterinary, and human health sciences.The major players in the Latin American Bioinformatics market areAffymetrix,Inc. (U.S.), Life Technologies Corporation (U.S.), Illumina, Inc. (U.S.), and CLC Bio (Denmark).
CLC Biois a bioinformatics software provider company that offers an analysis platform wherein both desktop and server software are integrated. CLC offers database solutions, computing solutions, server solutions, bioinformatics consulting solutions, and bioinformatics education solutions. The company offers consulting services through customization, integration, scientific applications, and customer projects. With its core technologies and platforms, CLC Bio intends to broaden the integration of informatics tools for effective data analysis. In accordance with this, the company concentrates on collaborating with other stakeholders.For example, in April 2013, CLC Bio teamed up with IBM to develop an integrated next-generation sequencing data analytics solution. Moreover, to cater to the demand of different sequence analysis suites from its broad customer base, the company strategically concentrates on developing new products with strong competitive capabilities. In this regard, CLC Bio focuses on building next-generation sequencing tools for explorative genomics research.
Affymetrix, Inc.is engaged in the development, production, and distribution of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets. It operates under two reportable business segments as Affymetrix Core and eBioscience. The company witnessed a growth of 10.5%, registering a total revenue worth $295.6 million in 2012 compared to $267.5 million in the previous year. The growth in revenue was attributed to the strong performance of Affymetrix Core that was mainly driven by its segments such as eBioscience, genetic analysis, and applications. Affymetrix aims to establish a sales, marketing, and technical support organization to strengthen its marketing capabilities. In this regard, the company strategically focuses on signing agreements with other stakeholders. Along with this,the company also focuses on new product launches to provide innovative and advanced bioinformatics technologies.
Illumina, Inc.is a molecular diagnostics company that is engaged in the development, manufacturing, and marketing of integrated systems for the analysis of genetic variations and biological functions. The company operates under two business segments, namely, the life sciences business unit and the diagnostics business unit. It also offers software and informatics platforms including cloud-based computational tools for its sequencing- and array-based systems. Illumina witnessed a growth of 8.8%, reporting $1,148.5 million in 2012 compared to $1,055.5 million in 2011. This increase was attributed to the high sales of sequencing consumables and the increase in installed base of sequencing systems. Illumina seeks to expand its business in the Latin American region. Thus, to expand its business opportunities, in January 2011, Illumina set up a new office at Sao Paolo, Brazil. Illumina is also focusing on the agricultural application in this market. However, this facility will support genetic research in human health and agriculture. This step will help strengthen its position in the Latin American market.
Thus, partnerships, agreements, collaborations, joint ventures, and acquisitions are the key growth strategies adopted by leading industry participants. Market players adopted these strategies to access new technologies, expand their products and services portfolio, enter into growing markets, and/or increase their market share.
Latin American Bioinformatics Market by Sector (Agriculture, Molecular Medicine, Research & Animal), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) - Forecasts to 2017
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252